PDS Biotechnology Corp
PDSB· Nasdaq
Released May 13, 2020, before the open
10-Q filed May 13, 2020, 43 days after period end · 0001140361-20-011497
| Metric | Q1 2020 | Q1 2019 | Q1 2018 | Q1 2017 |
|---|---|---|---|---|
| Net Income | -$3.99M | $6.82M | -$737.89K | -$12.17M |
| EPS Diluted | -$0.39 | $1.47 | -$0.24 | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
PDS Biotechnology Corp · CIK 1472091 · Engraved from SEC EDGAR